Jeffrey A. Cohen

Dartmouth–Hitchcock Medical Center — United States

Medicine · Health Sciences

82h-index31.6kcitations618works7.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(259), Peripheral Neuropathies and Disorders(88), Sphingolipid Metabolism and Signaling(36), Rheumatoid Arthritis Research and Therapies(33), Polyomavirus and related diseases(29)

Publications612 total

Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial
JCI Insight·2025Open Access
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial
Multiple Sclerosis Journal·2025· 1 citedOpen Access
Autologous haematopoietic stem cell transplantation in multiple sclerosis: where does it fit in the treatment algorithm?
Journal of Neurology Neurosurgery & Psychiatry·2025Open Access
Frequency of Seroconversion in Aquaporin‐4 Antibody Testing: Insights From Real‐World Data
Annals of Clinical and Translational Neurology·2025Open Access
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
The Lancet Neurology·2025· 138 cited
Volumetric <scp>MRI</scp> Comparing Longitudinal Change in <scp>MOGAD</scp> to <scp>NMOSD</scp> , <scp>MS</scp> and Healthy Controls, and Disability Associations
Annals of Neurology·2025· 1 citedOpen Access
Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials
Multiple Sclerosis Journal·2025Open Access
2024 revision of the McDonald diagnostic criteria for MS: Substantial and substantive changes
Multiple Sclerosis Journal·2025· 3 cited
Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis
Neurology and Therapy·2025· 7 citedOpen Access
Cognitive and Patient‐Reported Outcome Measures in <scp>LGI</scp>‐1‐<scp>IgG</scp> Autoimmune Encephalitis
Annals of Clinical and Translational Neurology·2025· 1 citedOpen Access
Whole Brain, Cortical Grey Matter, and Thalamic Volume Changes During 5–7 Years of Ozanimod in Relapsing MS: Final Results from the DAYBREAK Open-label Extension Study (P3-1.005)
Neurology·2025
Frequency of Seroconversion in Aquaporin-4 Antibody Testing: Insights from Real-World Data (P12-8.001)
Neurology·2025
ETV2 Overexpression Promotes Efficient Differentiation of Pluripotent Stem Cells to Endothelial Cells
Biotechnology and Bioengineering·2025· 3 citedOpen Access
Sécurité et efficacité à long terme de l’ofatumumab chez les personnes atteintes de sclérose en plaques récurrente pour une durée allant jusqu’à 6 ans
Revue Neurologique·2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis
JAMA Network Open·2025· 12 citedOpen Access
Progressive Myelitis in a 63-Year-Old Woman
Neurology Neuroimmunology & Neuroinflammation·2025· 3 citedOpen Access
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT
Nature Reviews Neurology·2025· 29 citedOpen Access
Liquidity and Spatial Spillovers of Accessory Dwelling Units in Housing Markets
SSRN Electronic Journal·2025Open Access
The onset presentation of multiple sclerosis differs in Hispanic/Latinx Americans compared with non-Hispanic White Americans
Multiple Sclerosis Journal·2024· 2 cited
S3 Integrated Long-Term Safety of Ozanimod Across Two Different Indications: Results from Clinical Trials in Patients With Moderately to Severely Active Ulcerative Colitis or Relapsing Multiple Sclerosis
The American Journal of Gastroenterology·2024
page 1 of 31Next →

Frequent Co-authors

Stephen C. Reingold(10), Ruth Ann Marrie(10), Gary Cutter(8), María Trojano(7), Alan J. Thompson(6), Olaf Stüve(6), Per Soelberg Sørensen(6), Xavier Montalbán(5), Gary M. Franklin(5), Nadia Reider(5), Ludwig Kappos(4), James F. Howard(4), Richard A. Lewis(4), Gıancarlo Comı(4), Richard A. Rudick(4), John D. England(4), Phillip A. Low(4), Amit Bar‐Or(4), Eva Havrdová(3), Fred Lublin(3)